11-12 September 2018 //  Lancaster Royal Hotel, London


Seokjoong Kim

Dr Seokjoong Kim

Research Director, ToolGen

Dr. Seokjoong Kim is an experienced molecular biologist in the field of programmable nuclease development and genome editing technology. Following his Ph.D. studies in the laboratory of Prof. Thomas Boyer at University of Texas Health Science Center at San Antonio, Dr. Kim joined the group of Prof. Jin-Soo Kim at Seoul National University as a postdoctoral researcher where he experienced the development of zinc finger nucleases and TAL effector nucleases. Since 2010, Dr. Kim is a Research and Business Development Director of ToolGen, Inc., a Korean biotech focusing on the translation of genome editing technology into valuable products in the field of therapeutics and agriculture. Current R&D is developing the strategies of therapeutic genome editing.


2017 Speakers

"It was a very interesting event as all participants, including speakers were ready to exchange, even on the most challenging subjects such as reimbursement, GMP guidance."

Bertrand Alexandre, Director, Marketing Europe, Celyad